Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Jan-20 6:36 PM View:  | Reardon Tighe Acting Chief Financial Officer | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 1,682,090 | $68.00 | $114,382,000.00 | (100%) 1.68M to 0 | |
| 24-Jan-20 6:23 PM View: | Kolchinsky Peter Director 10% Owner | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) Duplicate | 9,724,600 | $68.00 | $661,273,024.00 | (100%) 9.72M to 0 | |
| 24-Jan-20 5:11 PM View: | Ra Capital Management, LLC 10% Owner | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 9,724,600 | $68.00 | $661,273,024.00 | (100%) 9.72M to 0 | |
| 24-Jan-20 6:41 PM View: | Shawver Laura President and CEO Director | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 220,595 | $68.00 | $15,000,500.00 | (90%) 245.59K to 25.0K | |
| 24-Jan-20 6:31 PM View: | Milla Marcos Chief Scientific Officer | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 63,989 | $68.00 | $4,351,250.00 | (100%) 63.99K to 0 | |
| 24-Jan-20 6:41 PM View: | Shawver Laura President and CEO Director | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 25,000 | $68.00 | $1,700,000.00 | (100%) 25.0K to 0 | |
| 24-Jan-20 6:36 PM View: | Reardon Tighe Acting Chief Financial Officer | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 43,688 | $68.00 | $2,970,780.00 | (3%) 1.73M to 1.68M | |
| 24-Jan-20 6:26 PM View: | Leveque Joseph Chief Medical Officer | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 316,164 | $68.00 | $21,499,200.00 | (100%) 316.16K to 0 | |
| 24-Jan-20 6:38 PM View: | Shah Pratik Director | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 62,412 | $68.00 | $4,244,020.00 | (100%) 62.41K to 0 | |
| 24-Jan-20 6:44 PM View: | Thompson Peter A Director 10% Owner | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 5,316,360 | $68.00 | $361,512,000.00 | (100%) 5.32M to 0 | |
| 24-Jan-20 6:28 PM View: | Lichter Jay Director | Synthorx, Inc. (THOR) | 23-Jan-20 | Disposition (change in control) | 2,280,650 | $68.00 | $155,084,000.00 | (100%) 2.28M to 0 | |
| 16-Jan-20 4:24 PM View: | Lichter Jay Director | Synthorx, Inc. (THOR) | 14-Jan-20 | Acquisition (other) | 448,567 | -- | -- | 7% 6.43M to 6.88M | |
| 16-Jan-20 4:21 PM View: | Avalon Ventures X, L.P. 10% Owner | Synthorx, Inc. (THOR) | 14-Jan-20 | Disposition (other) | 4,598,800 | -- | -- | (72%) 6.43M to 1.83M | |
| 16-Jan-20 4:24 PM View: | Lichter Jay Director | Synthorx, Inc. (THOR) | 14-Jan-20 | Disposition (other) Duplicate | 4,598,800 | -- | -- | (67%) 6.88M to 2.28M | |
| 24-Jan-20 6:41 PM View: | Shawver Laura President and CEO Director | Synthorx, Inc. (THOR) | 08-Jan-20 | Gift | 80,706 | -- | -- | (25%) 321.3K to 240.59K | |
| 02-Jan-20 4:39 PM View: | Shawver Laura President and CEO Director | Synthorx, Inc. (THOR) | 30-Dec-19 | Option Exercise | 379,453 | $4.02 | $1,525,320.00 | 250% 151.86K to 531.31K | |
| 02-Jan-20 4:41 PM View: | Milla Marcos Chief Scientific Officer | Synthorx, Inc. (THOR) | 30-Dec-19 | Option Exercise | 98,000 | $0.63 | $61,740.00 | 544% 18.0K to 116.0K | |
| 02-Jan-20 4:43 PM View: | Leveque Joseph Chief Medical Officer | Synthorx, Inc. (THOR) | 30-Dec-19 | Payment of Exercise | 45,019 | $70.63 | $3,179,690.00 | (13%) 358.91K to 313.89K | |
| 02-Jan-20 4:43 PM View: | Leveque Joseph Chief Medical Officer | Synthorx, Inc. (THOR) | 30-Dec-19 | Option Exercise | 75,000 | $11.00 | $825,000.00 | 26% 283.91K to 358.91K | |
| 02-Jan-20 4:41 PM View: | Milla Marcos Chief Scientific Officer | Synthorx, Inc. (THOR) | 30-Dec-19 | Payment of Exercise | 52,011 | $70.63 | $3,673,540.00 | (45%) 116.0K to 63.99K | |
| 02-Jan-20 4:39 PM View: | Shawver Laura President and CEO Director | Synthorx, Inc. (THOR) | 30-Dec-19 | Payment of Exercise | 210,010 | $70.63 | $14,833,000.00 | (40%) 531.31K to 321.3K | |
| 19-Dec-19 4:41 PM View: | Shawver Laura President and CEO Director | Synthorx, Inc. (THOR) | 18-Dec-19 | Grant | 45,000 | -- | -- | 42% 106.86K to 151.86K | |
| 19-Dec-19 4:39 PM View: | Milla Marcos Chief Scientific Officer | Synthorx, Inc. (THOR) | 17-Dec-19 | Grant | 18,000 | -- | -- | 100% 0 to 18.0K | |
| 19-Dec-19 4:38 PM View: | Leveque Joseph Chief Medical Officer | Synthorx, Inc. (THOR) | 17-Dec-19 | Grant | 20,000 | -- | -- | 8% 263.91K to 283.91K | |
| 25-Jan-19 4:33 PM View: | Shawver Laura President and CEO Director | Synthorx, Inc. (THOR) | 24-Jan-19 | Option Exercise | 25,000 | $0.63 | $15,750.00 | 31% 80.71K to 105.71K | |
| 13-Dec-18 6:36 PM View: | Reardon Tighe Acting Chief Financial Officer | Synthorx, Inc. (THOR) | 11-Dec-18 | Conversion Duplicate | 1,136,630 | -- | -- | 2602% 43.69K to 1.18M | |
| 13-Dec-18 6:35 PM View: | Lichter Jay Director 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Conversion | 5,698,190 | -- | -- | 430% 1.32M to 7.02M | |
| 13-Dec-18 6:37 PM View: | Thompson Peter A Director 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Conversion Duplicate | 3,952,720 | -- | -- | 100% 0 to 3.95M | |
| 13-Dec-18 6:33 PM View: | Orbimed Advisors LLC Director 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Conversion | 3,952,720 | -- | -- | 100% 0 to 3.95M | |
| 13-Dec-18 6:30 PM View: | Avalon Ventures X, L.P. 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Conversion | 1,136,630 | -- | -- | 24% 4.75M to 5.89M | |
| 13-Dec-18 6:36 PM View: | Reardon Tighe Acting Chief Financial Officer | Synthorx, Inc. (THOR) | 11-Dec-18 | Purchase Duplicate | 545,455 | $11.00 | $6,000,000.00 | 46% 1.18M to 1.73M | |
| 13-Dec-18 6:35 PM View: | Lichter Jay Director 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Purchase Duplicate | 545,455 | $11.00 | $6,000,000.00 | 8% 7.02M to 7.57M | |
| 13-Dec-18 6:37 PM View: | Thompson Peter A Director 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Purchase Duplicate | 1,363,640 | $11.00 | $15,000,000.00 | 34% 3.95M to 5.32M | |
| 13-Dec-18 6:31 PM View: | Kolchinsky Peter Director 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Conversion Duplicate | 5,179,140 | -- | -- | 77% 6.7M to 11.88M | |
| 13-Dec-18 6:33 PM View: | Orbimed Advisors LLC Director 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Purchase | 1,363,640 | $11.00 | $15,000,000.00 | 34% 3.95M to 5.32M | |
| 13-Dec-18 6:30 PM View: | Ra Capital Management, LLC 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Conversion | 5,179,140 | -- | -- | 77% 6.7M to 11.88M | |
| 13-Dec-18 6:31 PM View: | Kolchinsky Peter Director 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Purchase Duplicate | 4,545,460 | $11.00 | $50,000,000.00 | 38% 11.88M to 16.43M | |
| 13-Dec-18 6:30 PM View: | Avalon Ventures X, L.P. 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Conversion | 4,561,560 | -- | -- | 2436% 187.24K to 4.75M | |
| 13-Dec-18 6:30 PM View: | Ra Capital Management, LLC 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Purchase | 4,545,460 | $11.00 | $50,000,000.00 | 38% 11.88M to 16.43M | |
| 13-Dec-18 6:30 PM View: | Avalon Ventures X, L.P. 10% Owner | Synthorx, Inc. (THOR) | 11-Dec-18 | Purchase | 545,455 | $11.00 | $6,000,000.00 | 9% 5.89M to 6.43M |
